BioMarin Pharmaceuticals BMRN Product One — Retained Earnings Accumulated Deficit
Discontinued — last reported Q4 '17
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: BioMarin Pharmaceuticals’s 10-K, filed February 28, 2019, on SEC EDGAR. View the filing →
Questions, answered.
- What does product one — retained earnings accumulated deficit mean?
- The cumulative historical profit or loss generated by this specific business segment.
- How do you interpret product one — retained earnings accumulated deficit?
- A positive trend indicates sustained segment profitability, while an increasing deficit suggests ongoing investment or lack of segment-level break-even.
- How does product one — retained earnings accumulated deficit compare across companies?
- Reflects the lifecycle stage of the product line, similar to accumulated earnings in other corporate divisions.